Cargando…
Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
High plasma levels of homocysteine, termed hyperhomocysteinemia, are a risk factor for vascular cognitive impairment and dementia, which is the second leading cause of dementia. While hyperhomocysteinemia induces microhemorrhages and cognitive decline in mice, the specific effect of hyperhomocystein...
Autores principales: | Weekman, Erica M., Woolums, Abigail E., Sudduth, Tiffany L., Wilcock, Donna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718317/ https://www.ncbi.nlm.nih.gov/pubmed/29198136 http://dx.doi.org/10.1177/1759091417742296 |
Ejemplares similares
-
Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes
por: Weekman, Erica M., et al.
Publicado: (2023) -
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014) -
Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019) -
Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue
por: Weekman, Erica M., et al.
Publicado: (2022) -
Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)